Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine
Authors (first, second and last of 7)
![](https://media.springernature.com/w290h158/springer-static/image/art%3A10.1186%2Fs10194-021-01215-9/MediaObjects/10194_2021_1215_Fig1_HTML.png)
Official Journal of the "European Headache Federation" and of "Lifting The Burden - The Global Campaign against Headache"
156 articles in this issue